Rigel Pharmaceuticals Inc. (RIGL) Stock Price Peaks at $1.1400 During Trading


The closing price of Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) was $1.07 for the day, down -6.14% from the previous closing price of $1.14. In other words, the price has decreased by -$0.0700 from its previous closing price. On the day, 697649 shares were traded. RIGL stock price reached its highest trading level at $1.1400 during the session, while it also had its lowest trading level at $1.0600.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.



Our analysis of RIGL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.00 and its Current Ratio is at 2.30.

Upgrades & Downgrades

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 06 when RODRIGUEZ RAUL R sold 20,340 shares for $1.75 per share. The transaction valued at 35,595 led to the insider holds 1,680,713 shares of the business.

Dummer Wolfgang sold 5,389 shares of RIGL for $8,946 on Feb 02. The EVP & CMO now owns 72,459 shares after completing the transaction at $1.66 per share. On Feb 02, another insider, Schorno Dean L, who serves as the EVP & Chief Financial Officer of the company, sold 5,389 shares for $1.66 each. As a result, the insider received 8,946 and left with 196,519 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RIGL now has a Market Capitalization of 186.57M and an Enterprise Value of 182.88M. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.47. Its current Enterprise Value per Revenue stands at 1.41 whereas that against EBITDA is -4.59.

Stock Price History:

Over the past 52 weeks, RIGL has reached a high of $2.04, while it has fallen to a 52-week low of $0.67. The 50-Day Moving Average of the stock is 1.2084, while the 200-Day Moving Average is calculated to be 1.3611.

Shares Statistics:

RIGL traded an average of 1.23M shares per day over the past three months and 955.47k shares per day over the past ten days. A total of 173.75M shares are outstanding, with a floating share count of 171.87M. Insiders hold about 1.44% of the company’s shares, while institutions hold 77.60% stake in the company. Shares short for RIGL as of Aug 14, 2023 were 3.72M with a Short Ratio of 3.82M, compared to 3.85M on Jul 13, 2023. Therefore, it implies a Short% of Shares Outstanding of 2.13% and a Short% of Float of 2.16%.

Earnings Estimates

The firm’s stock currently is rated by 6 analysts. On average, analysts expect EPS of -$0.07 for the current quarter, with a high estimate of -$0.06 and a low estimate of -$0.09, while EPS last year was -$0.11. The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.06 and low estimates of -$0.09.

Analysts are recommending an EPS of between -$0.24 and -$0.29 for the fiscal current year, implying an average EPS of -$0.26. EPS for the following year is -$0.14, with 6 analysts recommending between -$0.1 and -$0.2.

Revenue Estimates

It is expected that $90B in revenue will be generated in the current quarter, according to 5 analysts. It ranges from a high estimate of $28.82M to a low estimate of $24.7M. As of the current estimate, Rigel Pharmaceuticals Inc.’s year-ago sales were $22.61M, an estimated increase of 20.30% from the year-ago figure. For the next quarter, 5 analysts are estimating revenue of $28.95M, a decrease of -43.50% less than the figure of $20.30% in the same quarter last year. There is a high estimate of $30.97M for the next quarter, whereas the lowest estimate is $25.7M.

A total of 6 analysts have provided revenue estimates for RIGL’s current fiscal year. The highest revenue estimate was $124.64M, while the lowest revenue estimate was $103.3M, resulting in an average revenue estimate of $111.2M. In the same quarter a year ago, actual revenue was $120.24M, down -7.50% from the average estimate. Based on 6 analysts’ estimates, the company’s revenue will be $135.69M in the next fiscal year. The high estimate is $143.9M and the low estimate is $111.01M. The average revenue growth estimate for next year is up 22.00% from the average revenue estimate for this year.


Please enter your comment!
Please enter your name here